Change Location × Atlanta

    Recent Locations

      Improving Outcomes in Giant Cell Arteritis: Multidisciplinary Perspectives on How to Implement the Latest Evidence-based Care in Atlanta

      • Improving Outcomes in Giant Cell Arteritis: Multidisciplinary Perspectives on How to Implement the Latest Evidence-based Care Photo #1
      1 of 1
      November 10, 2019

      Sunday   6:00 PM

      International Ballroom EF; North Tower, M2 , 100 CNN Center NW
      Atlanta, Georgia

      • No Performers Listed
      Improving Outcomes in Giant Cell Arteritis: Multidisciplinary Perspectives on How to Implement the Latest Evidence-based Care

      This program is intended for 2019 ACR/ARP Annual Meeting attendees only. Activity Chair Leonard H. Calabrese, DO Professor of Medicine Cleveland Clinic Lerner College of Medicine Case Western Reserve University R.J. Fasenmyer Chair of Clinical Immunology Cleveland Clinic Cleveland, OH Faculty Michael S. Lee, MD Professor, Departments of Ophthalmology and Visual Neurosciences, Neurosurgery, and NeurologyMackall-Scheie Research ChairDirector, Ophthalmology Residency ProgramDirector, Neuro-Ophthalmology ServiceUniversity of Minnesota Minneapolis, MN  John H. Stone, MD, MPH Professor of Medicine Harvard Medical School The Edward Fox Chair in Medicine Director, Clinical Rheumatology Massachusetts General Hospital Boston, MA Kenneth J. Warrington, MD John F. Finn Minnesota Arthritis Foundation Professor of Medicine Mayo Clinic College of Medicine and Science Chair, Division of Rheumatology Mayo ClinicRochester, MN Overview Giant cell arteritis (GCA) is the most common form of medium- and large-vessel vasculitis. Despite new treatment options for patients with GCA, delays in diagnosis and treatment lead to poor outcomes, such as the increased risk for visual impairments and incidence of heart attacks, transient ischemic attacks, and/or mortality. Diagnosis of GCA remains difficult due to the nonspecific nature of many early symptoms. Until recently, therapeutic options were limited to prolonged, high-dose glucocorticoid therapy, which has the potential for many undesirable side effects. In this CME activity, expert faculty will discuss the clinical and immunopathologic features of GCA as well as current therapeutic options, including latest evidence regarding biologics and the impact on the  need for steroids. Strategies for how to adopt a multidisciplinary approach for the care of patients with GCA will be discussed. Agenda 6:00 PMRegistration and Dinner 6:30 PMIntroduction and PretestLeonard H. Calabrese, DO 6:45 PM Early Recognition and Diagnosis of GCAKenneth J. Warrington, MD 7:00 PM Panel Discussion 7:05 PMNeuro-Ophthalmology Perspective on the Diagnosis and Complications of GCAMichael S. Lee, MD 7:20 PMAdvances in GCA Treatment – How to Apply to PracticeJohn H. Stone, MD, MPH 7:45 PMPanel Discussion 7:50 PMClinical Cases 8:15 PMPosttest 8:20 PMQuestion and Answer 8:30 PMConclusion Learning Objectives Upon successful completion of this activity, participants should be better able to: Utilize appropriate medical workup and diagnostic tools to identify patients with GCA in a timely manner. Assess the latest evidence regarding the use of steroid-sparing regimens on long-term treatment response and health-related quality of life for patients with GCA. Implement evidence-based, glucocorticoid-sparing treatment strategies for patients with GCA. Adopt a multidisciplinary approach for the care of patients with GCA. Target Audience The intended audience for this activity is rheumatologists and other health care professionals involved in the management of patients with GCA. This continuing medical education activity is provided by Vindico Medical Education. This activity is supported by an educational grant from Genentech, Inc. This is not an official program of the American College of Rheumatology. This symposium will be conducted during the 2019 ACR/ARP Annual Meeting. Vindico Medical Education is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Vindico Medical Education designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. In accordance with the Accreditation Council for Continuing Medical Education’s Standards for Commercial Support, all planners, teachers, and authors involved in the development of CME content are required to disclose to the accredited provider their relevant financial relationships. Relevant financial relationships will be disclosed to the activity audience. Faculty, topics, program schedule, and credit hours are subject to change. Audiotaping or videotaping is prohibited without written permission from the program committee. MIPS Qualifying Activity:Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Participants who successfully complete the activity and its performance assessment will receive printable documentation of successful completion for MIPS self-reporting.

      Categories: Health & Wellness

      Event details may change at any time, always check with the event organizer when planning to attend this event or purchase tickets.